Moger, Tron Anders http://orcid.org/0000-0003-2865-4762
Holen, Åsne
Hanestad, Berit
Hofvind, Solveig
Funding for this research was provided by:
Norges Forskningsråd (247941/H10)
Kreftforeningen (190184-2017)
Article History
Accepted: 16 May 2022
First Online: 7 July 2022
Declarations
:
: This study was funded by the Research Council of Norway, grant no. 247941/H10 and the Norwegian Cancer Society, grant no. 190184-2017.
: Tron Anders Moger, Åsne Holen, Berit Hanestad and Solveig Hofvind declare that they have no conflict of interest.
: The To-Be trial was approved by the Regional Committees for Medical and Health Research Ethics in Norway, and registered at ClinicalTrials.gov (NCT02835625).
: Data used in the analyses will be available on request, given legal basis according to the GDPR, Article 6 and 9.
: All females who agreed to participate in the To-Be trial signed an electronic consent.
: Not applicable.
: Code for the model can be acquired by contacting the corresponding author.
: Tron Anders Moger wrote the manuscript, built the model and did the analyses; Åsne Holen provided data from the Cancer Registry of Norway and constructed the database used in the study; Berit Hanestad collected data on all treatment and procedure codes at Haukeland University Hospital for the participants in the trial; and Solveig Hofvind provided feedback on the manuscript throughout the work.